https://www.avient.com/knowledge-base/article/using-post-consumer-recycled-content-plastic-packaging-closures?rtype[]=1164
Ensure that cooling in the molds is operating efficiently and is balanced, and plan on revising the injection and temperature profiles
https://www.avient.com/knowledge-base/case-study/auto-supplier-drives-exceptional-quality-productivity?pname[]=10744
The material solution, Avient’s OnFlex-S EH UV TPE, offers an outstanding balance of processability, tactile qualities, UV resistance, abrasion resistance and colorability that capably satisfies the application’s requirements.
https://www.avient.com/news/polyone-features-polymer-solutions-and-services-designed-specifically-mexico-and-central-america-plastimagen
In addition, Maxxam™ XST materials offer an exceptional balance of stiffness and impact performance for automotive interior design, even in cold temperatures.
https://www.avient.com/news/polyone-launches-new-textile-printing-technology-china-wilflex-epic-rio-non-phthalate-ink-mixing-system
EPIC Rio inks are PANTONE® approved, with an extended color range of 18 single pigment finished ink mixing components, which balance color accuracy, vibrancy and opacity for peak press performance and color design.
https://www.avient.com/news/avient-s-malm-sweden-site-earns-iscc-plus-certification-mevopur-healthcare-bio-based-polymer-solutions
Following the mass balance chain-of-custody approach, the amount of bio-based content is tracked through segregated bookkeeping and provided in the sustainability declaration for the Mevopur healthcare bio-based portfolio.
https://www.avient.com/news/avient-colorforward-experts-predict-pandemic-likely-influence-color-preferences-even-2022
New, remote approaches to working will continue even after the pandemic is under control, according to the expert team, making it increasingly difficult to find a reasonable work/life balance.
https://www.avient.com/news/colorforward-predicts-2024-trends-more-harmonious-colors-splash-exuberance
The 2024 palette is more harmonious and balanced, with colors more evenly distributed across the color spectrum and only a slight emergence of the yellow and brown families.
https://www.avient.com/sites/default/files/2020-08/colormatrix-reprize-brochure-8.5x11.pdf
COLORMATRIX™ rePrize™ Liquid dispersion chain extender for PET monolayer, multilayer and foamed sheet ColorMatrix™ rePrize™ is a PET and PC compatible formulated liquid dispersion chain extender.
Added to the feed throat and designed to increase the polymer chain length via reactive extrusion, rePrize enables an increase in both the polymer intrinsic and melt viscosity. rePrize can be used to replace virgin PET in PET sheet, when virgin PET is used in combination with PCR flake or regrind, to increase the IV.
This results in an increase in both the polymer intrinsic and melt viscosity. rePrize is suited to applications in: • PET monolayer sheet • PET multilayered sheet • PET foamed sheet rePrize can be used to optimise sheet manufacturing processes and product quality, whilst allowing for increased levels of recycle, contributing towards improved sustainability and reduced costs PRODUCT DESCRIPTION GLOBAL REGULATORY APPROVALS PRODUCT FDA EU GB MERCOSUR rePrize • • • • 1.844.4AVIENT www.avient.com Copyright © 2020, Avient Corporation.
https://www.avient.com/sites/default/files/resources/PolyOne%2520IR%2520Presentation%2520-%2520RW%2520Baird%25202015%2520Industrial%2520Conference%2520-%2520November%25202015.pdf
PolyOne Corporation Page 4 PolyOne Commodity to Specialty Transformation • Volume driven, commodity producer • Heavily tied to cyclical end markets • Performance largely dependent on non- controlling joint ventures 2000-2005 2006 - 2009 2010 – 2014 2015 and beyond • Steve Newlin appointed, Chairman, President and CEO • New leadership team appointed • Implementation of four pillar strategy • Focus on value based selling, investment in commercial resources and innovation to drive transformation • Substantial EPS growth from $0.13 to all-time high of $1.80 • Shift to faster growing, high margin, less cyclical end markets • Key acquisitions propel current and future growth, as well as margin expansion • Specialty mix expands to 65% of Operating Income – strongest mix of earnings in history • Accelerating growth • Deliver consistent double digit annual EPS growth • Maintain >35% vitality index • Pursue strategic acquisitions that expand specialty offerings and geographic breadth • Invest and grow current and next generation talent PolyOne Corporation Page 5 Appliances 5% Building & Construction 12% Consumer 10% Electrical & Electronics 5% Healthcare 11% Industrial 14% Packaging 14% Transportation 20% Wire & Cable 9% Distribution 28% PP&S 20% Specialty 52% United States 69% Europe 13% Canada 7% Asia 6% Latin America 5% 2014 Revenues: $3.8 Billion End Markets 2014 Revenues: $3.8 Billion PolyOne At A Glance $0.12 $0.27 $0.21 $0.13 $0.68 $0.82 $1.00 $1.31 $1.80 2006 2007 2008 2009 2010 2011 2012 2013 2014 Adjusted EPS PolyOne Corporation Page 6 Old PolyOne *Operating Income excludes corporate charges and special items 2% 34% 43% 62% 65% 66% 0% 20% 40% 60% 80% 100% 2005 2008 2010 2013 2014 YTD 2015 2020 % o f O pe ra tin g In co m e* JV's Performance Products & Solutions Distribution Specialty 80%+ Specialty OI $5M $46M $87M $195M $242M $183M Mix Shift Highlights Specialty Transformation Transformation 2020 Platinum Vision Platinum Vision PolyOne Corporation Page 7 Confirmation of Our Strategy Specialization Globalization Operational Excellence Commercial Excellence Driven by our core values of Collaboration, Innovation and Excellence, we are the world’s premier provider of specialized polymer materials, services and solutions PolyOne Corporation Page 8 2006 YTD 2015 2020 “Where we were” “Where we are” Platinum Vision 1) Operating Income % Specialty: Global Color, Additives & Inks 1.7% 17.2% 20%+ Global Specialty Engineered Materials 1.1% 15.1% 20%+ Designed Structures & Solutions 1.4% (2012) 3.5% 12 – 14% Performance Products & Solutions 5.5% 8.1% 10 – 12% Distribution 2.6% 6.6% 6.5 – 7.5% 2) Specialty Platform % of Operating Income 6.0% 66% 80%+ 3) ROIC 5.0% 11.9% 15% 4) Adjusted EPS Growth N/A 24 Consecutive Quarters of YOY EPS Growth Double Digit Expansion Proof of Performance & 2020 Goals PolyOne Corporation Page 9 Innovation Drives Earnings Growth *Percentage of Specialty Platform revenue from products introduced in last five years $20 $52 2006 TTM Research & Development Spending ($ millions) Specialty Platform Vitality Index Progression* 14% 28% 2006 TTM Specialty Platform Gross Margin % 12% 43% 2006 TTM Specialty Vitality Index Target ≥ 35% TTM 9/30/15 TTM 9/30/15 TTM 9/30/15 PolyOne Corporation Page 10 Innovation Pipeline Potential Prototype Frame Opportunity Scale-up & Test Market Build Business Case Commercial Launch Phase 1 Phase 2 Phase 3 Phase 4 Phase 5 12 4 9 6 1 6 3 7 4 5 6 1 1 7 2 Breakthrough Platform Derivative Number of Projects 12 10 23 19 10 74 Specialty Addressable Market ($ millions) - - $1,150 $1,000 $250 $2,400 PolyOne Corporation Page 11 Lightweighting with Advanced Composites Increasing Healthcare Penetration Innovation Initiatives Expansion in Consumer Markets New Market Development $$$ $$ $ High Temperature Polymers PolyOne Corporation Page 12 Design and Service as a Differentiator Right Material & Color Desired Product Design Appropriate Manufacturing Process Delivering Concept to Commercialization Connecting the Dots with iQ Design Labs and InVisiO Color Design PolyOne Corporation Page 13 Customer First Through World-Class Service Strengthening relationships through: Providing LSS services to small/medium sized customers • Supporting customers who lack their own formal process improvement initiatives Providing training in Customer Centric Selling Skills with customers’ sales force PolyOne Corporation Page 14 60% 97% 20% 30% 40% 50% 60% 70% 80% 90% 100% 2008 Q3 2015 Pension Funding** As of September 30, 2015 Debt Maturities & Pension Funding Net Debt / Adjusted EBITDA** = 2.1x $49 $121 $317 $600 $400 $0 $100 $200 $300 $400 $500 $600 $700 $800 2015 2018 2020 2023 Debt Maturities As of September 30, 2015 ($ millions) Coupon Rate: 7.500% Variable* 7.375% 5.250% ** includes US-qualified pension plans only *Weighted average rate on revolver was 2.49% as of 9/30/15 **TTM 9/30/2015 PolyOne Corporation Page 15 Free Cash Flow and Strong Balance Sheet Fund Investment / Shareholder Return Expanding our sales, marketing, and technical capabilities Investing in operational and LSS initiatives ~75% of capital expenditures fund growth initiatives Organic Growth Acquisitions Share Repurchases Dividends $0.16 $0.20 $0.32 $0.40 $0.48 $0.10 $0.20 $0.30 $0.40 $0.50 2011 2012 2013 2014 2015 2016 Annual Dividend Targets that expand our: • Specialty offerings • End market presence • Geographic breadth Synergy opportunities Adjacent material solutions Repurchased nearly 2.4 million shares in Q3 2015 Repurchased 14.8 million shares since early 2013 5.2 million shares are available for repurchase under the current authorization $0.24 PolyOne Corporation Page 16 The New PolyOne: A Specialty Growth Company Why Invest In PolyOne?
Trailing twelve months adjusted gross margin is calculated as follows: Three Months Ended Nine Months Ended Trailing Twelve Months (TTM) Ended (In millions) December 31, 2014 September 30, 2015 September 30, 2015 Gross margin - GAAP $ 152.6 $ 524.6 $ 677.2 Special items in gross margin 15.8 30.0 45.8 Gross margin excluding special items $ 168.4 $ 554.6 $ 723.0 Adjusted EBITDA and net debt to adjusted EBITDA is calculated as follows: Three Months Ended Nine Months Ended Trailing Twelve Months (TTM) Ended (In millions) December 31, 2014 September 30, 2015 September 30, 2015 Income from continuing operations, before income taxes $ (31.2) $ 168.1 $ 136.9 Interest expense, net 15.6 48.5 64.1 Depreciation and amortization 25.0 78.4 103.4 Special items, impact on income from continuing operations before income taxes 80.8 39.8 120.6 Accelerated depreciation included in special items (0.2) (4.6) (4.8) Adjusted EBITDA $ 90.0 $ 330.2 $ 420.2 Short-term portion and current portion of long-term debt $ 61.8 Long-term debt 1,038.0 Less: Cash and cash equivalents (235.7) Net Debt 864.1 Net Debt/TTM Adjusted EBITDA 2.1 Baird Non GAAP Rec Baird - November 10, 2015 POL IR Presentation - November 2015 11.5.2015 - Website ��PolyOne Investor Presentation�RW Baird 2015 Industrial Conference�November 2015�� Forward-Looking Statements Use of Non-GAAP Measures PolyOne Commodity to Specialty Transformation PolyOne�At A Glance Mix Shift Highlights Specialty Transformation Confirmation of Our Strategy Proof of Performance & 2020 Goals Innovation Drives Earnings Growth Innovation Pipeline Potential Innovation Initiatives Design and Service as a Differentiator Customer First Through World-Class Service Debt Maturities & Pension Funding Free Cash Flow and Strong Balance Sheet �Fund Investment / Shareholder Return Why Invest In PolyOne?
https://www.avient.com/sites/default/files/resources/Gabelli%2520Conf%2520-%2520POL%2520IR%2520Presentation%2520wNon%2520GAAP%2520Reconciliation%252003%252026%252015.pdf
S&P 500 All time high of $43.34 July 1st, 2014 PolyOne Corporation Page 9 2006 2014 2015 Target “Where we were” “Where we are” (Est. in 2012) 1) Operating Income % Specialty: Global Color, Additives & Inks 1.7% 14.7% 12 – 16% Global Specialty Engineered Materials 1.1% 12.1% 12 – 16% Designed Structures & Solutions 1.4% (2012) 7.3% 8 – 10% Performance Products & Solutions 5.5% 7.7% 9 – 12% Distribution 2.6% 6.1% 6 – 7.5% 2) Specialty Platform % of Operating Income 6.0% 65% 65 – 75% 3) ROIC* 5.0% 11.3% 15% 4) Adjusted EPS Growth N/A 37% Double Digit Expansion *ROIC is defined as TTM adjusted OI divided by the sum of average debt and equity over a 5 quarter period Proof of Performance & 2015 Goals PolyOne Corporation Page 10 Continuing Earnings Growth Double Digit EPS Expansion Ongoing LSS Programs Incremental Share Buybacks Mergers & Acquisitions Continued Gross Margin Expansion Mid Single Digit Revenue Growth Accelerated Innovation & Mix Improvement PolyOne Corporation Page 11 Innovation Drives Earnings Growth *Percentage of Specialty Platform revenue from products introduced in last five years $20 $53 2006 2014 Research & Development Spending ($ millions) Specialty Platform Vitality Index Progression* 14% 27% 2006 2014 Specialty Platform Gross Margin % 20% 44% 2006 2014 Specialty Vitality Index Target ≥ 35% PolyOne Corporation Page 12 Megatrends Aligned with Key End Markets Decreasing Dependence on Fossil Fuels Protecting the Environment Improving Health and Wellness Megatrend End Markets Globalizing and Localizing Health & Wellness Transportation Packaging Consumer PolyOne Corporation Page 13 60% 94% 20% 30% 40% 50% 60% 70% 80% 90% 100% 2008 2014 Pension Funding** As of December 31, 2014 Debt Maturities & Pension Funding – 12/31/14 Net Debt / EBITDA* = 1.9x $49 $317 $600 $0 $100 $200 $300 $400 $500 $600 $700 $800 2015 2020 2023 Debt Maturities As of December 31, 2014 ($ millions) Coupon Rate: 7.500% 7.375% 5.250% ** includes US-qualified pension plans only *TTM 12/31/2014 PolyOne Corporation Page 14 Free Cash Flow and Strong Balance Sheet Fund Investment / Shareholder Return Expanding our sales, marketing, and technical capabilities Investing in operational and LSS initiatives (including synergy capture) ~75% of capital expenditures fund growth initiatives Organic Growth Acquisitions Share Repurchases Dividends $0.16 $0.20 $0.24 $0.32 $0.40 $0.10 $0.20 $0.30 $0.40 $0.50 2011 2012 2013 2014 2015 Annual Dividend Targets that expand our: • Specialty offerings • End market presence • Geographic breadth • Operating Margin Synergy opportunities Adjacent material solutions Repurchased 1.6 million shares in Q4 2014 Repurchased 11.3 million shares since early 2013 8.7 million shares are available for repurchase under the current authorization PolyOne Corporation Page 15 PolyOne Core Values Innovation Collaboration Excellence PolyOne Corporation Page 16 The New PolyOne: A Specialty Growth Company Why Invest In PolyOne?
Gabelli Conf - POL IR Presentation ��PolyOne Investor Presentation�Gabelli Specialty Chemicals Conference�March 2015�� Forward-Looking Statements Use of Non-GAAP Measures PolyOne Commodity to Specialty Transformation PolyOne�At A Glance Mix Shift Highlights Specialty Transformation Confirmation of Our Strategy Strategy and Execution Drive Results Proof of Performance & 2015 Goals Continuing Earnings Growth Innovation Drives Earnings Growth Megatrends Aligned with Key End Markets Debt Maturities & Pension Funding – 12/31/14 Free Cash Flow and Strong Balance Sheet �Fund Investment / Shareholder Return PolyOne Core Values Why Invest In PolyOne?